| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BX-912 | GDSC1000 | pan-cancer | AAC | 0.16 | 3e-06 |
| mRNA | GSK1070916 | GDSC1000 | pan-cancer | AAC | 0.16 | 6e-06 |
| mRNA | NPK76-II-72-1 | GDSC1000 | pan-cancer | AAC | 0.13 | 0.0001 |
| mRNA | FTI-277 | GDSC1000 | pan-cancer | AAC | -0.14 | 0.0001 |
| mRNA | Cetuximab | GDSC1000 | pan-cancer | AAC | -0.13 | 0.0003 |
| mRNA | 17-AAG | GDSC1000 | pan-cancer | AAC | -0.13 | 0.0003 |
| mRNA | PF-562271 | GDSC1000 | pan-cancer | AAC | -0.14 | 0.0004 |
| mRNA | WZ3105 | GDSC1000 | pan-cancer | AAC | 0.12 | 0.0005 |
| mRNA | ML239 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0005 |
| mRNA | darinaparsin | CTRPv2 | pan-cancer | AAC | 0.18 | 0.0009 |